小肠细菌过度生长的治疗新进展  

New progress in treatment of intestinal bacterial overgrowth

作　　者：高雯雯[1] 张翔[1] 王红 尹雁惠 Gao Wenwen;Zhang Xiang;Wang Hong;Yin Yanhui(Department of Clinical Pharmacy,Jinan Central Hospital,Jinan 250013,China)

机构地区：[1]济南市中心医院临床药学科,济南250013

出　　处：《国际医药卫生导报》2024年第9期1418-1421,共4页International Medicine and Health Guidance News

基　　金：济南市卫生健康委员会科技发展计划(2022-2-04)。

摘　　要：小肠细菌过度生长(SIBO)是由多种因素引起的小肠细菌含量高于正常值,并且与肠易激综合征、炎症性肠病等多种疾病相关。目前,关于SIBO的治疗方法仍有争议。因此,本文对SIBO的治疗进行综述,包括抗菌药物、益生菌、促动力药、中草药、饮食疗法及其他治疗方法。Small intestinal bacterial overgrowth(SIBO)is defined as an increase in the bacterial content of the small intestine above the normal value and is associated with various diseases,such as irritable bowel syndrome,inflammatory diseases,etc.The treatment for SIBO is still controversial.Therefore,this article reviews treatments for SIBO,including antibiotic,probiotics,prokinetic,herbal therapy,dietary therapies,and other treatments.

关 键 词：小肠细菌过度生长 利福昔明 益生菌 进展 

分 类 号：R574[医药卫生—消化系统]